MedPath

A Study to Compare Analytes in Blood Collected Using an Investigational Collection Device With a Commercial Predicate

Not Applicable
Withdrawn
Conditions
Anemia
Diabetes
Interventions
Device: SAFE-T-FILL CAPILLARY BLOOD COLLECTION SYSTEM
Device: TAP20-C
Registration Number
NCT01786408
Lead Sponsor
Seventh Sense Biosystems
Brief Summary

This study will involve an investigational device, the Seventh Sense Biosystems TAP20-C. The TAP20-C device collects small amounts of blood from the forearm which can then be used for blood testing. The study will also involve collecting blood by fingerstick which is a common way of collecting blood. The SAFE-T-FILL Capillary Blood Collection system and the Terumo Capiject 1.5 mm Blade Safety Lancet will be used for this. The study will compare the concentrations of glucose, hemoglobin, and HbA1C in blood samples collected with the two different blood collection methods. Additional information will be collected about how the TAP20-C device performs.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Healthy Subject Group

  1. Male and female volunteers 18 years of age or older

Diabetic Subject Group

  1. Male and female volunteers 18 years of age or older
  2. Have been diagnosed with Type 1 or Type 2 diabetes mellitus by self-report
Exclusion Criteria

1.Subjects who are pregnant or nursing mothers by self report 2.Subjects who have eaten or consumed sugar-containing drinks in the 2 hours before blood sample collection begins 3.Subjects with a history of skin disorders or who present with abnormal skin integrity or atypical skin health within the areas to be tested 4.Subjects with a missing index or middle finger on either hand or a missing forearm 5.Subjects who have known allergies to titanium

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SAFE-T-FILL CAPILLARY SYSTEMSAFE-T-FILL CAPILLARY BLOOD COLLECTION SYSTEMSingle Use Capillary Blood Collection System
TAP20-CTAP20-CSingle Use Integrated Capillary Blood Collection System
Primary Outcome Measures
NameTimeMethod
Non-Inferiority of Analyte LevelsDay 1

The study will compare the concentrations of glucose, hemoglobin, and HbA1C in blood samples collected with the two different blood collection methods in a single two hour session.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seventh Sense BIosystems

🇺🇸

Cambridge, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath